Presently there are no disease-modifying therapies for the treatment of Parkinson’s disease; however, one potential strategy for treatment is to prevent α-synuclein aggregation.
Source: News Medical, https://www.news-medical.net/
Presently there are no disease-modifying therapies for the treatment of Parkinson’s disease; however, one potential strategy for treatment is to prevent α-synuclein aggregation.
Source: News Medical, https://www.news-medical.net/